Research Directory

Baxdrostat gets FDA priority review

Read more

Reflections on JP Morgan meeting

Read more

Contours of the new EU pharma legislation are visible

Read more

EU pharma reform meets US MFN pricing

Read more

Compassionate Use - Ensuring access to critical medicines

Read more

How PARP inhibitors prevent the survival of cancers

Read more

Pharmacovigilance is at a crossroads

Read more

Trends in investment for cell and gene therapies

Read more

Achieving federated analysis through partnership, by Philip Quinlan

Read more

New opportunities awaited travellers to San Francisco

Read more